Nanochon

Nanochon

Biotechnology Research Washington, Dc, United States 13 employees
Employees
13
Contacts
4
Emails
4
Phones
3

Nanochon Overview

Headquarters
Washington, Dc, United States
Website
nanochon.com
Industry
Biotechnology Research
Employees
13
Founded
2016
Company Email
Available in AeroLeads
NAICS
Research and Development in Biotechnology (except Nanobiotechnology)

About Nanochon

At present, there is an established clinical standard for treating joint disease: the total joint replacement. Yet, while the surgical devices and techniques used to implant them have been largely perfected, today’s standard replacement joints are very invasive, and not permanent. The lifespan of common replacement joints limits their effective use in patients aged 55 or older. This leaves patients between ages 18 and 55 suffering from cartilage damage, traumatic injury, or early stage cartilage loss with limited treatment options. Nanochon, is developing an implant designed to not only replace lost and damaged cartilage, but also to encourage new tissue growth. Using 3-D printing and a novel material, the Nanochon implant is a sturdy medical advancement that is both an orthopedic load bearing implant as well a tissue growth scaffold. The Nanochon implant has the potential to deliver faster and more successful recoveries for patients, while reducing costs to health providers, payers, and patients. Nanochon’s aim is to set a new clinical standard for cartilage restoration.

Nanochon Contact Details

People in AeroLeads
4
With contact data
4
Email contacts
4
100.0% coverage
Phone contacts
3
75.0% coverage

Nanochon Org Chart

Sample employees and titles
Name Title Contact
Nathan Castro Co-founder and CTO @ Nanochon, Inc
Email
Jenny Chen Pitch3d, No Nda
Email Phone
Gary Wakeford Mba Med Tech Executive Excelling
Email Phone
Kurt Jacobus
Email Phone

Employees by Management Level

Individual contributor 3 profiles
Executive 1 profile

Compare Similar Companies to Nanochon